{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:59:48Z","timestamp":1790719188034,"version":"4.1.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.intimp.2009.02.004","type":"journal-article","created":{"date-parts":[[2009,2,27]],"date-time":"2009-02-27T04:28:52Z","timestamp":1235708932000},"page":"645-648","source":"Crossref","is-referenced-by-count":33,"title":["Elevated serum levels of M30 and M65 in patients with locally advanced head and neck tumors"],"prefix":"10.1016","volume":"9","author":[{"given":"Banu","family":"Ozturk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugur","family":"Coskun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banu","family":"Sancak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emel","family":"Yaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suleyman","family":"Buyukberber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Benekli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2009.02.004_bib1","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1083\/jcb.138.6.1379","article-title":"Caspase cleavage of keratin 18 and reorganization of intermediate filaments during epithelial cell apoptosis","volume":"138","author":"Caul\u00edn","year":"1997","journal-title":"J Cell Biol"},{"key":"10.1016\/j.intimp.2009.02.004_bib2","doi-asserted-by":"crossref","first-page":"33197","DOI":"10.1074\/jbc.272.52.33197","article-title":"Apoptosis generates stable fragments of human type I keratins","volume":"272","author":"Ku","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.intimp.2009.02.004_bib3","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1083\/jcb.148.6.1239","article-title":"Active caspases and cleaved cytokeratins are sequestered into cytoplasmic inclusions in TRAIL-induced apoptosis","volume":"148","author":"MacFarlane","year":"2000","journal-title":"J Cell Biol"},{"key":"10.1016\/j.intimp.2009.02.004_bib4","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/(SICI)1096-9896(199904)187:5<567::AID-PATH288>3.0.CO;2-J","article-title":"Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis","volume":"187","author":"Leers","year":"1999","journal-title":"J Pathol"},{"key":"10.1016\/j.intimp.2009.02.004_bib5","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1038\/sj.cdd.4402148","article-title":"Cell death modalities: classification and pathophysiological implications","volume":"14","author":"Galluzzi","year":"2007","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.intimp.2009.02.004_bib6","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/sj.bjc.6602363","article-title":"Validation of pharmacodynamic assays to evaluate the clinical efficacy of an antisense compound (AEG 35156) targeted to the X-linked inhibitor of apoptosis protein XIAP","volume":"92","author":"Cummings","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/j.intimp.2009.02.004_bib7","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1038\/sj.bjc.6603129","article-title":"Docetaxel induces apoptosis in hormone refractory prostate carcinomas during multiple treatment cycles","volume":"94","author":"Kramer","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.intimp.2009.02.004_bib8","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/sj.bjc.6603220","article-title":"Method validation and preliminary qualification of pharmacodynamic biomarkers employed to evaluate the clinical efficacy of an antisense compound (AEG35156) targeted to the X-linked inhibitor of apoptosis protein XIAP","volume":"95","author":"Cummings","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.intimp.2009.02.004_bib9","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00280-007-0437-4","article-title":"Qualification of M30 and M65 ELISAs as surrogate biomarkers of cell death: long term antigen stability in cancer patient plasma","volume":"60","author":"Cummings","year":"2007","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.intimp.2009.02.004_bib10","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0959-8049(02)00865-1","article-title":"Measurement of an apoptotic product in the sera of breast cancer patients","volume":"39","author":"Ueno","year":"2003","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.intimp.2009.02.004_bib11","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.lungcan.2007.01.015","article-title":"The levels of caspase-cleaved cytokeratin 18 are elevated in serum from patients with lung cancer and helpful to predict the survival","volume":"56","author":"Ulukaya","year":"2007","journal-title":"Lung Cancer"},{"key":"10.1016\/j.intimp.2009.02.004_bib12","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1593\/neo.08620","article-title":"Clinical evaluation of M30 and M65 ELISA cell death assays as circulating biomarkers in a drug-sensitive tumor, testicular cancer","volume":"10","author":"de Haas","year":"2008","journal-title":"Neoplasia"},{"key":"10.1016\/j.intimp.2009.02.004_bib13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.yexcr.2004.02.019","article-title":"Keratin 8\/18 breakdown and reorganization during apoptosis","volume":"297","author":"Schutte","year":"2004","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.intimp.2009.02.004_bib14","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1023\/A:1023672805949","article-title":"A novel assay for discovery and characterization of pro-apoptotic drugs and for monitoring apoptosis in patient sera","volume":"8","author":"Biv\u00e9n","year":"2003","journal-title":"Apoptosis"},{"key":"10.1016\/j.intimp.2009.02.004_bib15","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1080\/07357900600981307","article-title":"Response to neoadjuvant chemotherapy in breast cancer could be predictable by measuring a novel serum apoptosis product, caspase-cleaved cytokeratin 18: a prospective pilot study","volume":"24","author":"Demiray","year":"2006","journal-title":"Cancer Invest"},{"key":"10.1016\/j.intimp.2009.02.004_bib16","first-page":"314","article-title":"Study on expression of Ki-67, early apoptotic protein M30 in endometrial carcinoma and their correlation with prognosis","volume":"32","author":"Wu","year":"2003","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"10.1016\/j.intimp.2009.02.004_bib17","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1093\/annonc\/mdn014","article-title":"Optimisation of circulating biomarkers of cell death for routine clinical use","volume":"19","author":"Greystoke","year":"2008","journal-title":"Ann Oncol"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576909000654?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576909000654?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,18]],"date-time":"2019-05-18T05:22:03Z","timestamp":1558156923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576909000654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S1567576909000654"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2009.02.004","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}